Related Experiment Videos
Summary
Treating chronic intrahepatic cholestasis involves symptomatic relief for itching and causal therapies. Ursodeoxycholic acid is a primary treatment, proving effective in various cholestatic conditions and aiding liver transplantation candidates.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Context:
- Chronic intrahepatic cholestasis presents significant management challenges.
- Current therapeutic strategies include symptomatic and causal approaches.
- Pruritus is a major symptom requiring targeted treatment.
Purpose:
- To review current therapeutic options for chronic intrahepatic cholestasis.
- To highlight the efficacy of ursodeoxycholic acid in causal treatment.
- To discuss supportive therapies for symptom management.
Summary:
- Symptomatic treatment focuses on pruritus, utilizing cholestyramine, Rifadine, and promising opiate antagonists.
- Causal treatment is dominated by ursodeoxycholic acid, with proven benefits in controlled studies.
- Ursodeoxycholic acid is effective for primary biliary cirrhosis, primary sclerosing cholangitis, and other cholestatic diseases.
Impact:
- Ursodeoxycholic acid offers a proven causal therapy for various cholestatic liver diseases.
- Effective management of cholestasis can improve patient quality of life.
- In advanced stages, ursodeoxycholic acid can be a precursor to liver transplantation.